Related Experiment Video
Updated: Dec 12, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Triptonide Modulates MAPK Signaling Pathways and Exerts Anticancer Effects via ER Stress-Mediated Apoptosis Induction
Liyun Zheng1,2, Shiji Fang1,2, Junguo Hui3
1Interventional Diagnosis and Treatment Center, Lishui Hospital of Zhejiang University, Lishui, Zhejiang 323000, People's Republic of China.
Background:
Osteosarcoma (OS) is the most common primary malignancy arise from bone and is one of the causes of cancer-related deaths. Triptonide (TN), a diterpenoid epoxide presented in Tripterygium wilfordii, is shown to possess a broad spectrum of biological properties.
Methods:
In this study, we investigate the growth inhibitory effect of TN against human OS cells and its underlying molecular mechanism of action.
Results:
Findings of our in vitro study revealed that TN exhibited a dose-dependent cytotoxic effect in MG63 and U-2OS cells. ROS-mediated cytotoxic effect was achieved in OS cells treated with TN which was reversed upon NAC treatment. Significantly, increased expression of PERK, p-EIF2, GRP78, ATF4 and CHOP in TN-treated OS cells unfolds the molecular mechanism of TN targets ER stress-mediated apoptosis. Modulation of ERK MAPK pathway was also observed as evidenced by the increased phosphorylation of ERK (p-ERK) and p-p38 in TN-treated OS cells.
Conclusion:
Altogether, the outcome of the study for the first time revealed that TN exhibited its potential chemotherapeutic effects through ROS-mediated ER stress-induced apoptosis via p38 and ERK MAPK signaling pathways.
Insights
Triptonide (TN) shows potential as a chemotherapy agent for osteosarcoma (OS). It induces cancer cell death by triggering reactive oxygen species (ROS)-mediated endoplasmic reticulum (ER) stress and apoptosis through MAPK signaling pathways.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Osteosarcoma (OS) is a primary bone cancer and a significant cause of cancer mortality.
- Triptonide (TN), derived from Tripterygium wilfordii, exhibits diverse biological activities.
Purpose of the Study:
- To investigate the anti-cancer effects of Triptonide (TN) on human osteosarcoma (OS) cells.
- To elucidate the molecular mechanisms underlying TN's cytotoxic action in OS.
Main Methods:
- In vitro assessment of TN's cytotoxic effects on MG63 and U-2OS osteosarcoma cell lines.
- Analysis of reactive oxygen species (ROS) generation and endoplasmic reticulum (ER) stress markers (PERK, p-EIF2, GRP78, ATF4, CHOP).
- Evaluation of mitogen-activated protein kinase (MAPK) pathway modulation, including ERK and p38 phosphorylation.
Main Results:
- TN demonstrated a dose-dependent cytotoxic effect on OS cells.
- TN-induced cytotoxicity was mediated by increased ROS production, which was reversed by N-acetylcysteine (NAC).
- TN treatment upregulated ER stress markers and modulated ERK and p38 MAPK pathways, indicating apoptosis induction.
Conclusions:
- Triptonide (TN) exhibits chemotherapeutic potential against osteosarcoma.
- TN induces apoptosis in OS cells via ROS-mediated ER stress, involving the p38 and ERK MAPK signaling pathways.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

